Plaque psoriasis is the most common type of psoriasis. It makes up about 90% of cases. It’s also known as psoriasis vulgaris. Vulgaris is the Latin word for “common.” Plaque psoriasis on ...

Plaque psoriasis is the most common type. It appears as plaques, which are raised patches of skin covered in silvery-white scales. Plaques typically appear on the scalp, trunk, and limbs and are ...

Risankizumab was associated with more significant improvements among patients with plaque psoriasis when compared with other biologic therapies.

Discover a study that investigates spesolimab, a monoclonal antibody that has been approved as the first GPP-specific therapy ...

Recent study findings highlight the value of integrating behavioral modification and Health Belief Model–based education into ...

Thaçi noted that TYK2 mediates cytokine signaling that includes pro-inflammatory molecules known to be involved in psoriasis and PsA, such as interleukin (IL)-12, IL-23, and type I interferon.

Can-Fite BioPharma (CANF) initiated a pivotal phase 3 psoriasis study of its oral drug Piclidenoson with the U.S. Food and Drug Administration ...

Once-daily ICP-488 significantly improved PASI scores in patients with plaque psoriasis compared with placebo at week 12. The safety profile of ICP-488 was similar to placebo. ORLANDO — A once ...